1. Home
  2. LASR vs XENE Comparison

LASR vs XENE Comparison

Compare LASR & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo nLIGHT Inc.

LASR

nLIGHT Inc.

N/A

Current Price

$32.74

Market Cap

4.1B

Sector

Technology

ML Signal

N/A

Logo Xenon Pharmaceuticals Inc.

XENE

Xenon Pharmaceuticals Inc.

N/A

Current Price

$37.04

Market Cap

3.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LASR
XENE
Founded
2000
1996
Country
United States
Canada
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.7B
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
LASR
XENE
Price
$32.74
$37.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
18
Target Price
$59.50
★ $71.56
AVG Volume (30 Days)
941.2K
★ 1.2M
Earning Date
11-05-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 62.99
N/A
EPS
★ N/A
N/A
Revenue
★ $191,359,000.00
$311,000.00
Revenue This Year
$23.89
N/A
Revenue Next Year
$15.89
$1,974.47
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 38.09
N/A
52 Week Low
$28.70
$33.38
52 Week High
$86.95
$72.66

Technical Indicators

Market Signals
Indicator
LASR
XENE
Relative Strength Index (RSI) 37.92 40.41
Support Level $28.70 $33.38
Resistance Level $40.79 $37.00
Average True Range (ATR) 2.86 1.51
MACD -0.41 -0.05
Stochastic Oscillator 20.89 1.84

Price Performance

Historical Comparison
LASR
XENE

About LASR nLIGHT Inc.

nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products segment, which includes semiconductor lasers, fiber lasers, and directed energy products; and Advanced Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA, of which maximum revenue is derived from North America.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: